Ineffectiveness of vasopressin in the treatment of memory impairment in chronic schizophrenia

Daniel Stein, Jacob Bannet, Ilya Averbuch, Leonid Landa, Shella Chazan, Robert H. Belmaker

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Abstract

A vasopressin derivative or placebo was administered to 21 chronic schizophrenia patients for 3 weeks in a randomized crossover double-blind design. The patients were divided into those above and below the median on baseline memory measured by the Wechsler memory scale. Vasopressin treatment did not improve memory either in those patients with below median baseline memory or in the group as a whole.

Original languageEnglish
Pages (from-to)566-568
Number of pages3
JournalPsychopharmacology
Volume84
Issue number4
DOIs
StatePublished - 1 Dec 1984
Externally publishedYes

Keywords

  • Memory
  • Schizophrenia
  • Vasopressin

ASJC Scopus subject areas

  • Pharmacology

Fingerprint

Dive into the research topics of 'Ineffectiveness of vasopressin in the treatment of memory impairment in chronic schizophrenia'. Together they form a unique fingerprint.

Cite this